Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 17;9(10):e109842.
doi: 10.1371/journal.pone.0109842. eCollection 2014.

Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury

Affiliations

Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury

Lan Chen et al. PLoS One. .

Erratum in

  • PLoS One. 2014;9(12):e115469

Abstract

Objectives: Transient receptor potential vanilloid 1 (TRPV1) -positive sensory nerves are widely distributed in the kidney, suggesting that TRPV1-mediated action may participate in the regulation of renal function under pathophysiological conditions. Stimulation of TRPV1 channels protects against ischemia/reperfusion (I/R)-induced acute kidney injury (AKI). However, it is unknown whether inhibition of these channels is detrimental in AKI or not. We tested the role of TRPV1 channels in I/R-induced AKI by modulating these channels with capsaicin (TRPV1 agonist), capsazepine (TRPV1 antagonist) and using Trpv1-/- mice.

Methods and results: Anesthetized C57BL/6 mice were subjected to 25 min of renal ischemia and 24 hrs of reperfusion. Mice were pretreated with capsaicin (0.3 mg/kg body weight) or capsazepine (50 mg/kg body weight). Capsaicin ameliorated the outcome of AKI, as measured by serum creatinine levels, tubular damage,neutrophil gelatinase-associated lipocalin (NGAL) abundance and Ly-6B.2 positive polymorphonuclear inflammatory cells in injured kidneys. Neither capsazepine nor deficiency of TRPV1 did deteriorate renal function or histology after AKI. Measurements of endovanilloids in kidney tissue indicate that 20-hydroxyeicosatetraeonic acid (20-HETE) or epoxyeicosatrienoic acids (EETs) are unlikely involved in the beneficial effects of capsaicin on I/R-induced AKI.

Conclusions: Activation of TRPV1 channels ameliorates I/R-induced AKI, but inhibition of these channels does not affect the outcome of AKI. Our results may have clinical implications for long-term safety of renal denervation to treat resistant hypertension in man, with respect to the function of primary sensory nerves in the response of the kidney to ischemic stimuli.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Serum creatinine levels in mice subjected to renal I/R injury were ameliorated by pretreatment with capsaicin, but not capsazepine or genetic ablation of TRPV1.
Control, control mice that underwent sham surgery (nephrectomy) without I/R. I/R Control, control mice that underwent renal I/R injury. Capsaicin I/R, wild-type mice pretreated with capsaicin followed by renal I/R injury. Capsazepine I/R, wild-type mice pretreated with capsazepine followed by renal I/R injury. Trpv1−/− mice that underwent renal I/R injury. *P<0.05. P>0.05; not significant.
Figure 2
Figure 2. Amelioration of tubular damage score of I/R-induced AKI by pretreatment of mice with capsaicin, but not with capsazepine or genetic ablation of TRPV1.
Panel A: Tubular damage scores of ipsilateral kidneys (I/R Control) and kidneys after I/R (I/R) of control mice. Tubular damage scores of ipsilateral kidneys (Capsaicin C) and kidneys after I/R injury (Capsaicin I/R) of mice pretreated with capsaicin. Tubular damage scores of ipsilateral kidneys (Capsazepine C) and kidneys after I/R injury (Capsazepine I/R) of mice pretreated with capsazepine. Tubular damage scores of ipsilateral kidneys (Trpv1−/− C) and kidneys after I/R injury (Trpv1−/− I/R) of Trpv1−/− mice. Scores of ipsilateral control kidneys without I/R injury were all 0. *, P<0.05. P≥0.05; not significant. Panel B: Histological sections. (a) I/R Control, histology of ipsilateral kidney before renal I/R injury of a control mouse. (b) I/R, histology of kidney after I/R injury of a control mouse. The section shows acute tubular necrosis characterized by loss of tubular epithelial cells (arrow) and shedding of the brush border (asterisk). (c) Capsaicin I/R, histology of kidney after I/R injury of a mouse pretreated with capsaicin. Acute tubular necrosis (arrow). (d) Trpv1−/− I/R, histology of kidney after I/R injury of a Trpv1−/− mouse. Acute tubular necrosis (arrow) and shedding of the brush border (asterisk). Scale bar 100 µm. Magnification × 200.
Figure 3
Figure 3. NGAL abundance in the kidney was lower in I/R-induced AKI in mice treated with capsaicin, but not with capsazepine or in Trpv1−/− mice.
Panels A: NGAL abundance of ipsilateral kidneys (I/R Control) and kidneys after I/R (I/R) injury of control mice. NGAL abundance of ipsilateral kidneys (Capsaicin C) and kidneys after I/R injury (Capsaicin I/R) of mice pretreated with capsaicin. NGAL abundance of ipsilateral kidneys (Capsazepine C) and kidneys after I/R injury (Capsazepine I/R) of mice treated with capsazepine. NGAL abundance of ipsilateral kidneys (Trpv1−/− C) and kidneys after I/R injury (Trpv1−/− I/R) of Trpv1−/− mice. *, P<0.05. P>0.05; not significant. Panels B: Immunohistological sections. (a) I/R Control, images of NGAL negative staining of ipsilateral kidney before renal I/R injury of a control mouse. (b) I/R, intense renal NGAL staining after I/R injury of a control mouse. (c) Capsaicin I/R, renal NGAL staining after I/R injury of a mouse pretreated with capsaicin. (d) Trpv1−/− I/R, renal NGAL staining after I/R injury of a Trpv1−/− mouse. Scale bar 100 µm. Magnification ×200.
Figure 4
Figure 4. Lower Ly-6B.2 positive cells in the kidneys after I/R-induced AKI in mice treated with capsaicin, but not with capsazepine or in Trpv1−/− mice.
Ly-6B.2 positive cells were analyzed in the medulla (red color in panels B, marked by arrows). Panels A: Ly-6B.2 positive cells per field view in ipsilateral kidneys (I/R Control) and kidneys after I/R (I/R) injury of control mice. Ly-6B.2 positive cells in ipsilateral kidneys (Capsaicin C) and kidneys after I/R injury (Capsaicin I/R) of mice pretreated with capsaicin. Ly-6B.2 positive cells in ipsilateral kidneys (Capsazepine C) and kidneys after I/R injury (Capsazepine I/R) of mice treated with capsazepine. Ly-6B.2 positive cells in ipsilateral kidneys (Trpv1−/− C) and kidneys after I/R injury (Trpv1−/− I/R) of Trpv1−/− mice. *, P<0.05. P>0.05; not significant. Panels B: Immunohistological sections. (a) I/R Control, images of Ly-6B.2 positive cells in ipsilateral kidney before renal I/R injury of a control mouse. (b) I/R, Ly-6B.2 positive cells in a kidney after I/R injury of a control mouse. (c) Capsaicin I/R, Ly-6B.2 positive cells in a kidney after I/R injury of a mouse pretreated with capsaicin. (d) Trpv1−/− I/R, Ly-6B.2 positive cells in a kidney after I/R injury of a Trpv1−/− mouse. Scale bar 50 µm. Magnification ×400.
Figure 5
Figure 5. Eicosanoids and anandamide levels in non-ischemic (control) and ischemic (I) kidneys of (WT) wild-type mice after I-induced AKI.
5,6-EET, 5,6-epoxyeicosatrienoic acid; 8,9-EET, 8,9-epoxyeicosatrienoic acid; 11,12-EET, 11,12-epoxyeicosatrienoic acid; 14,15-EET, 14,15-epoxyeicosatrienoic acid; 5,6-DHET, 5,6-dihydroxyeicosastrienoic acid; 8,9-DHET, 8,9-dihydroxyeicosastrienoic acid; 11,12-DHET, 11,12-dihydroxyeicosastrienoic acid; 14,15-DHET, 14,15-dihydroxyeicosastrienoic acid; 20-HETE, 20-hydroxyeicosatetraenoic acid; 9,10-EPOME, 9(10)epoxy-9Z-octadecenoic acid; 12,13-EPOME, 12(13)epoxy-9Z-octadecenoic acid; 9,10-DIHOME, 9(10)-dihydroxy-12Z-octadecenoic acid; 9,10-DIHOME, 9(10)-dihydroxy-12Z-octadecenoic acid. n = 5 in each group.
Figure 6
Figure 6. Eicosanoids and anandamide levels in non-ischemic (I/R Control) and ischemic (I/R) kidneys of wild-type mice after I/R-induced AKI, in non-ischemic (Capsaicin C) and ischemic (Capsaicin I/R) kidneys of wild-type mice after I/R-induced AKI, and in non-ischemic (Trpv1−/− C) and ischemic (Trpv1−/− I/R) kidneys of Trpv1−/− mice after I/R-induced AKI. n>8 in each group.

References

    1. Barajas L, Liu L, Powers K (1992) Anatomy of the renal innervation: intrarenal aspects and ganglia of origin. Can J Physiol Pharmacol 70: 735–749 Available: http://www.ncbi.nlm.nih.gov/pubmed/1423018 Accessed 1 April 2014. - PubMed
    1. Ditting T, Freisinger W, Siegel K, Fiedler C, Small L, et al. (2012) Tonic postganglionic sympathetic inhibition induced by afferent renal nerves? Hypertension 59: 467–476 Available: http://www.ncbi.nlm.nih.gov/pubmed/22215714 Accessed 2014 April 1. - PubMed
    1. Wang Y, Chen AF, Wang DH (2005) ET(A) receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation. Am J Physiol Heart Circ Physiol 289: H2005–11 Available: http://www.ncbi.nlm.nih.gov/pubmed/15994858 Accessed 1 April 2014. - PubMed
    1. Xie C, Wang DH (2010) Effects of a high-salt diet on TRPV-1-dependent renal nerve activity in Dahl salt-sensitive rats. Am J Nephrol 32: 194–200 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2980518&tool=p... Accessed 2014 April 1. - PMC - PubMed
    1. Yang D, Luo Z, Ma S, Wong WT, Ma L, et al. (2010) Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 12: 130–141 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3906919&tool=p... Accessed 2014 April 1. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources